Moderna shares fell 3% Thursday afternoon, after reports that federal health officials are re-evaluating the company’s $590 million contract to help develop a bird-flu vaccine. Moderna was awarded the ...

A new study from Memorial Sloan Kettering Cancer Center shows good results for patients with pancreatic cancer. They used a personalized mRNA vaccine, which offers new hope. This pancreatic cancer ...

The news was reported by Bloomberg late Wednesday, citing people familiar with the matter. In the final days of President Joe Biden's term, Moderna (MRNA) won the $590 million contract to use its mRNA ...

This protein from tardigrades may hold the key to protecting healthy tissues during cancer radiation treatment.

Moderna Inc.'s stock tumbled 4% Thursday, after a report that health officials are reviewing a contract the company won from the Biden administration to support its efforts to develop a bird-flu ...

Taiwanese scientists have discovered a new way to synthesize circular RNA (circRNA), which could be applied to vaccine ...

The Trump administration confirmed it's reviewing whether to pull $590 million in funding that Moderna received in the final ...

IPA's strategy melds AI-driven analytics with specialised wet-lab methodologies to design and optimise antibodies.

Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future. One way Moderna has been trying to appease investors and reduce its losses ...

A $590 million contract awarded to Moderna by the U.S. government to aid in vaccine development for bird flu is being ...

A new type of mRNA vaccine, added to standard cancer treatment, could help some patients with pancreatic cancer live longer.

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...